Jilin Jian Yisheng Pharmaceutical Co (SZSE:002566) Total Liabilities : ¥701.3 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Jilin Jian Yisheng Pharmaceutical Co Total Liabilities?

Jilin Jian Yisheng Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥701.3 Mil.

Jilin Jian Yisheng Pharmaceutical Co's quarterly Total Liabilities declined from Sep. 2023 (¥739.93 Mil) to Dec. 2023 (¥714.30 Mil) and declined from Dec. 2023 (¥714.30 Mil) to Mar. 2024 (¥701.33 Mil).

Jilin Jian Yisheng Pharmaceutical Co's annual Total Liabilities increased from Dec. 2021 (¥666.08 Mil) to Dec. 2022 (¥717.18 Mil) but then declined from Dec. 2022 (¥717.18 Mil) to Dec. 2023 (¥714.30 Mil).

Jilin Jian Yisheng Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Jilin Jian Yisheng Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Jian Yisheng Pharmaceutical Co Total Liabilities Chart

Jilin Jian Yisheng Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

438.66

673.41

666.08

717.18

714.30

Jilin Jian Yisheng Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															732.06	729.96	739.93	714.30	701.33

Jilin Jian Yisheng Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Jilin Jian Yisheng Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	589.845	+	(4.026	+	120.431
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	714.3

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3046.722	-	2332.421
	=	714.3

Jilin Jian Yisheng Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	577.732	+	(2.709	+	120.889
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	701.3

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	3055.167	-	2353.837
	=	701.3

Jilin Jian Yisheng Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Jilin Jian Yisheng Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jilin Jian Yisheng Pharmaceutical Co (SZSE:002566) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jilin Jian Yisheng Pharmaceutical Co Ltd (SZSE:002566) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.17-20 Wenhuadong Road J, Jian City, CHN, 134200

Website

http://www.yisheng-pharm.com

Jilin Jian Yisheng Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceuticals, health foods, and cosmetics.

Executives

Xue Xiao Min	Executives
Li Fang Rong	Executives
Zhang Yi Sheng	Director
Liu Jian Ming	Executives
Cai Meng Jie	Executives
Qu Bo	Executives

Jilin Jian Yisheng Pharmaceutical Co (SZSE:002566) Headlines

No Headlines